313576
Lessons learned (or not) from the Bhopal Disaster
Methods: The Bhopal population is the largest natural laboratory of an accidental chemical release and presented an opportunity to help survivors and study the long-term effects of MIC toxicity in human beings. Much could have been learnt to benefit gas victims as well as future populations impacted by disaster. A review of studies will be done to determine the extent of our knowledge on the disaster.
Results: This talk will evaluate the medical and scientific investigation since 1984 and discuss the lessons learned and not learned from the disaster.
Conclusions: This presentation reviews the background of the Bhopal disaster as a case-study and presents recommendations for investigation and mitigation of health effects for future disasters.
Learning Areas:
Environmental health sciencesEpidemiology
Ethics, professional and legal requirements
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Provision of health care to the public
Learning Objectives:
Describe the long-term health effects of the disaster
Evaluate the conduct of health studies and their lacunae
Discuss the lessons learned from this accident and their application for disaster management
Keyword(s): Chemical Exposures & Prevention, Disasters
Qualified on the content I am responsible for because: As a member of the International Medical Commission on Bhopal disaster, I have designed and published the first long-term health effects studies on the exposed community. My work on exposure assessment in the gas victims is being used as a teaching tool in environmental epidemiology. I am actively involved in the reviewing and researching the long-term effects of the disaster and have published numerous papers on the subject.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.